The serpin proteinase inhibitor 8: An endogenous furin inhibitor released from human platelets

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH05-08-0561
Issue:2006: 95/2 (Feb) pp. 205-395
Pages:243-252

The serpin proteinase inhibitor 8: An endogenous furin inhibitor released from human platelets

Julie Leblond1 , Marie-Hélène Laprise 1 , Simon Gaudreau1 , Francine Grondin 1 , Walter Kisiel 2 , Claire M. Dubois
1 Immunology Division, Faculty of Medicine, Université de Sherbrooke, Sherbrooke, Qc, Canada; 2 Department of Pathology, University of New Mexico School of Medicine, Albuquerque, New Mexico, U

Summary

The cornerstone of hemostasis is the ability of the organism tolimit the enzymatic processes involved, thereby avoiding thrombosis.For this, anticoagulant systems in place involve serpins,such as PAI-1 and antithrombin III, which bind to their targetedserine proteases and limit their period of activity.We have previouslyidentified the serine protease furin as a platelet-derivedenzyme with an intrinsic role in platelet functions.We now reportthat furin enzymatic activity decreased rapidly followingplatelet activation,corresponding with the increase in formationof a high 180 M r SDS-stable complex composed of furin and the PI8 serpin.PI8 is shown to be a platelet-derived constituent,synthesizedby megakaryocytes and stored in platelets prior to itsrelease. Immunoprecipitation and purification of the PI8-furincomplex confirmed their direct interaction and indicates thatone of the roles of PI8 is to inhibit furin enzymatic activity. Furthermore,our findings demonstrate the inhibitory capacity ofexogenous PI8 in platelet aggregation assays.The finding that PI8is released by platelets and controls functional responses suggestsa role for this serpin in platelet-regulated pathophysiologicalresponses.

Keywords

Platelets, Proteinase inhibitor 8, serpin, furin, furin inhibitor

DOI

http://dx.doi.org/10.1160/TH05-08-0561

You may also be interested in...

1.

Sasidhar Guthikonda1, Kirankumar Mangalpally1, Muthiah Vaduganathan1, Rajnikant Patel2, Timothy DeLao1, Angela L. Bergeron3, Jing-Fei Dong3, Eli I. Lev1, Neal S. Kleiman1

Thrombosis and Haemostasis 2008 100 1: 83-89

http://dx.doi.org/10.1160/TH07-10-0590

2.

Ok-Nam Bae*1, Young-Dae Kim*1, Kyung-Min Lim1,2, Ji-Yoon Noh1, Seung-Min Chung1, Keunyoung Kim1, Suyoung Hong1, Sue Shin3, Jong-Hyun Yoon3, Jin-Ho Chung1

Thrombosis and Haemostasis 2008 100 1: 52-59

http://dx.doi.org/10.1160/TH07-08-0529

3.

Jing-fei Dong1,2*, Miguel A. Cruz1, Khatira Aboulfatova1, Cecilia Martin1, Hiuwan Choi1, Angela L. Bergeron1, Sheryl R. Martini3, Michael H. Kroll1,2, Thomas A. Kent3

Thrombosis and Haemostasis 2008 99 3: 586-593

http://dx.doi.org/10.1160/TH07-11-0694



Articles

You've 439 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...